Entera Bio Ltd. (ENTX) stock forecast and price target
Price $3.11 · data as of November 13, 2026
12-month price target
Average target$9.75
Upside / downside+213.5%
Analysts4
ConsensusStrong buy
Low $9.00Average $9.75High $11.00
Gold marker: average target · white marker: today’s price ($3.11)
Analyst ratings
Strong buy 0Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.42 | — | $0 |
| Next fiscal year ends December 31, 2027 | $-0.44 | — | $0 |
| Next quarter ends December 31, 2026 | $-0.12 | — | $0 |
| Quarter after ends March 31, 2027 | $-0.12 | — | $0 |
Consensus of the analysts covering Entera Bio, updated daily.
Frequently asked questions
What is the Entera Bio stock price target?
The average 12-month target from 4 analysts is $9.75, 213.5% above the current price of $3.11 Targets range from $9.00 to $11.00.
Is Entera Bio a buy according to analysts?
The consensus rating is “Strong buy” (5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Entera Bio expected to earn?
Analysts expect EPS of $-0.42 for the fiscal year ending December 31, 2026 and $-0.44 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.